Effectiveness of Lurasidone 80 mg in Patients with Schizophrenia: Results of an Open-Label, 12-Week Extension Study

PURPOSE: To evaluate the effectiveness and safety of lurasidone 80 mg/day (versus the 40 mg/day dose) during a 12-week, open-label extension study in patients with an acute exacerbation of schizophrenia who had completed a 6-week double-blind study of lurasidone. PATIENTS AND METHODS: A total of 289...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Itaru, Watabe, Kei, Sakaguchi, Reiko, Okamoto, Keisuke, Maruyama, Hidenori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656454/
https://www.ncbi.nlm.nih.gov/pubmed/36387943
http://dx.doi.org/10.2147/NDT.S380627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656454/
https://www.ncbi.nlm.nih.gov/pubmed/36387943
http://dx.doi.org/10.2147/NDT.S380627

Ejemplares similares